FAP and gastric cancer: In conclusion, FAP, CD10, and GPR77 labeled CAF subgroup may promote gastric cancer progression, and lead to NCT resistance and poor prognosis by inducing EMT and CSC of gastric cancer cells in locally advanced gastric cancer patients.